Imipenem-Relebactam For Treatment Of Carbapenemresistant Gram-Negative Bacteria: Where Do We Stand On In Vitro Susceptibility Testing? Reply
CLINICAL INFECTIOUS DISEASES（2021）
关键词
CLSI,Carbapenem resistance,EUCAST,Gram-negative bacteria,Imipenem/relebactam,Interpretive MIC breakpoints,Multi-drug resistance
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要